PARK HA BIOLOGICAL TECHNOLOG (BYAH) Stock Price, Forecast & Analysis
USA - NASDAQ:BYAH - KYG6925R1020 - Common Stock
BYAH Key Statistics, Chart & Performance
The current stock price of BYAH is 0.3001 USD.
BYAH Latest News, Press Relases and Analysis
BYAH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TSCO | TRACTOR SUPPLY COMPANY | 26.66 | 29.39B | ||
| ULTA | ULTA BEAUTY INC | 19.78 | 23.16B | ||
| DKS | DICK'S SPORTING GOODS INC | 15.7 | 19.70B | ||
| CHWY | CHEWY INC - CLASS A | 93.92 | 14.03B | ||
| FIVE | FIVE BELOW | 27.38 | 8.41B | ||
| BBWI | BATH & BODY WORKS INC | 6.52 | 4.62B | ||
| ASO | ACADEMY SPORTS & OUTDOORS IN | 7.95 | 2.99B | ||
| WRBY | WARBY PARKER INC-CLASS A | 43.48 | 2.12B | ||
| EYE | NATIONAL VISION HOLDINGS INC | 39.57 | 1.91B | ||
| WINA | WINMARK CORP | 38.26 | 1.53B | ||
| SBH | SALLY BEAUTY HOLDINGS INC | 7.59 | 1.40B | ||
| UPBD | UPBOUND GROUP INC | 4.2 | 1.01B |
Related stock screener links
About BYAH
Company Profile
Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
Company Info
PARK HA BIOLOGICAL TECHNOLOG
14F, Building 3, No. 50 Xiuxi Road
Wuxi JIANGSU CN
Employees: 31
Phone: 864000127562
PARK HA BIOLOGICAL TECHNOLOG / BYAH FAQ
Can you describe the business of PARK HA BIOLOGICAL TECHNOLOG?
Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
What is the current price of BYAH stock?
The current stock price of BYAH is 0.3001 USD. The price increased by 6.38% in the last trading session.
What is the dividend status of PARK HA BIOLOGICAL TECHNOLOG?
BYAH does not pay a dividend.
How is the ChartMill rating for PARK HA BIOLOGICAL TECHNOLOG?
BYAH has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is PARK HA BIOLOGICAL TECHNOLOG worth?
PARK HA BIOLOGICAL TECHNOLOG (BYAH) has a market capitalization of 10.16M USD. This makes BYAH a Nano Cap stock.
BYAH Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to BYAH.
BYAH Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BYAH. While BYAH has a great health rating, there are worries on its profitability.
BYAH Financial Highlights
Over the last trailing twelve months BYAH reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS decreased by -2189.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -331.89% | ||
| ROE | -455.43% | ||
| Debt/Equity | 0 |